Stock Events

Stock Events

Search...

C4 Therapeutics (CCCC) Q3 2023 Earnings

1NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.76

-0.69

-0.62

-0.55

Details

Expected EPS

-0.66

Actual EPS

-0.55

Surprise EPS

0.11

Surprise Percent

+16.67%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.55 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.